Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury

[1]  R. Reimer,et al.  Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice , 2018, Scientific Reports.

[2]  Ray-Jade Chen,et al.  Interleukin 15 activates Akt to protect astrocytes from oxygen glucose deprivation‐induced cell death , 2017, Cytokine.

[3]  Zamir Merali,et al.  Evolution of blood-brain-barrier permeability after acute ischemic stroke , 2017, PloS one.

[4]  F. Shi,et al.  Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity , 2016, Proceedings of the National Academy of Sciences.

[5]  C. Iadecola,et al.  Inflammation and Stroke: An Overview , 2016, Neurotherapeutics.

[6]  C. Chen,et al.  Splenic Responses in Ischemic Stroke: New Insights into Stroke Pathology , 2015, CNS neuroscience & therapeutics.

[7]  F. Sharp,et al.  Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Wei Zhou,et al.  Antigen Dependently Activated Cluster of Differentiation 8-Positive T Cells Cause Perforin-Mediated Neurotoxicity in Experimental Stroke , 2014, The Journal of Neuroscience.

[9]  V. Flamand,et al.  Unbalanced Neonatal CD4+ T-Cell Immunity , 2014, Front. Immunol..

[10]  S. Jiang,et al.  Adipocyte IL-15 Regulates Local and Systemic NK Cell Development , 2014, The Journal of Immunology.

[11]  M. Pichichero,et al.  Immune responses in neonates , 2014, Expert review of clinical immunology.

[12]  Ulrich Dirnagl,et al.  Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes. , 2014, Stroke.

[13]  F. Shi,et al.  Ischemic neurons recruit natural killer cells that accelerate brain infarction , 2014, Proceedings of the National Academy of Sciences.

[14]  L. Harrington,et al.  Astrocytes Modulate the Polarization of CD4+ T Cells to Th1 Cells , 2014, PloS one.

[15]  D. Lai,et al.  Isolation and Characterization of a Novel Strain of Mesenchymal Stem Cells from Mouse Umbilical Cord: Potential Application in Cell-Based Therapy , 2013, PloS one.

[16]  R. Ostrowski,et al.  Splenic Immune Cells in Experimental Neonatal Hypoxia–Ischemia , 2012, Translational Stroke Research.

[17]  R. Leak,et al.  Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia , 2012, Stroke.

[18]  K. Pennypacker,et al.  A Transient Decrease in Spleen Size Following Stroke Corresponds to Splenocyte Release into Systemic Circulation , 2012, Journal of Neuroimmune Pharmacology.

[19]  Baohui Xu,et al.  Distinctive Effects of T Cell Subsets in Neuronal Injury Induced by Cocultured Splenocytes In Vitro and by In Vivo Stroke in Mice , 2012, Stroke.

[20]  S. Jiang,et al.  Different NK Cell Developmental Events Require Different Levels of IL-15 Trans-Presentation , 2011, The Journal of Immunology.

[21]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[22]  David J Mikulis,et al.  Measuring permeability in acute ischemic stroke. , 2011, Neuroimaging clinics of North America.

[23]  Eric D. Peterson,et al.  Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic StrokeClinical Perspective , 2011 .

[24]  Yanxin Zhao,et al.  Targeting astrocytes for stroke therapy , 2010, Neurotherapeutics.

[25]  K. Schluns,et al.  Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. , 2010, Immunology letters.

[26]  D. Troxclair,et al.  Inchoate CD8+ T Cell Responses in Neonatal Mice Permit Influenza-Induced Persistent Pulmonary Dysfunction1 , 2008, The Journal of Immunology.

[27]  D. Gomez-Nicola,et al.  Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury , 2008, Glia.

[28]  A. Diefenbach,et al.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15. , 2007, Immunity.

[29]  Z. Vexler,et al.  Inflammation in adult and neonatal stroke , 2006, Clinical Neuroscience Research.

[30]  P. Burkett,et al.  Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.

[31]  T. Waldmann,et al.  IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[33]  F. Liew,et al.  IL‐15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL‐12 / IL‐4 stimulation in vitro , 2002, European journal of immunology.

[34]  J. Hsu,et al.  Reduced Expression of Bcl-2 in CD8+ T Cells Deficient in the IL-15 Receptor α-Chain1 , 2002, The Journal of Immunology.

[35]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[36]  V. Ramachandran,et al.  Regulated by the MicroRNA miR-181a Enhanced Activation-Dependent Signaling T Cells Have + Human Neonatal Naive CD4 , 2013 .

[37]  M. Sigaroudinia,et al.  Interleukin-12 Induces Interferon-γ Expression and Natural Killer Cytotoxicity in Cord Blood Mononuclear Cells1 , 1996, Pediatric Research.